1-3 of 3
Edward Kanfer, MD
Close
Sort by
Journal Articles

The Intensive Care Trial for Critically Ill Onco-Haematologic Patients: The Need for Response Criteria at 5 Days of Full Treatment to Separate Good Risk Patients and Avoid Futile Intensive Care Interventions

Silvia Monsalvo, Belen Sevillano, Andrew Innes, Maialen Lasa, MD, Laura Skinner, Richard Stumpfle, Syed Altaf, Eva Yebra, Donald MacDonald, Dragana Milojkovic, MD, Aristeidis Chaidos, Ian H Gabriel, Dr, Stephen J Brett, MD FRCA, FFICM, Robert Broomhead, Parind Patel, Umeer Waheed, Jiri Pavlu, MD FRCPath, Renuka Palanicawandar, Edward Kanfer, MD, Richard M Szydlo, Jane F. Apperley, MD, Eduardo Olavarria
Journal: Blood
Blood (2016) 128 (22): 5987.
https://doi.org/10.1182/blood.V128.22.5987.5987
Published: 2016
Journal Articles

Second Autologous Stem Cell Transplantation Is Effective Salvage Therapy for Relapsed Multiple Myeloma.

Aristeidis Chaidos, MD, PhD, Chrissy Giles, B.A.(Hons), Holger W Auner, Marco Bua, Jiri Pavlu, Ellena Smith, Edward Kanfer, MD, Donald MacDonald, Jane F. Apperley, MBChB, FRCP, FRCPath, Amin Rahemtulla, MBBS, PhD, FRCP
Journal: Blood
Blood (2009) 114 (22): 1229.
https://doi.org/10.1182/blood.V114.22.1229.1229
Published: 2009
Journal Articles

Presence of the Killer Immunoglobulin-Like Gene KIR3DS1 Is Associated with Poor Progression Free and Overall Survival Following Autologous Stem Cell Transplantation in Patients with Myeloma.

Ian H Gabriel, Dr, Ruhena Sargent, Dr, Hugues de Lavallade, Richard Szydlo, Jane Apperley, Ahmad Khoder, Dr, Abdullah Alsuliman, David Marin, Letizia Foroni, John Davis, Chrissy Giles, Edward Kanfer, MD, Amin Rahemtulla, MBBS, PhD, FRCP, Katayoun Rezvani, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 2840.
https://doi.org/10.1182/blood.V114.22.2840.2840
Published: 2009